Bio Usa News Today

The Chinese electric vehicle company lags American rival Tesla and homegrown challenger BYD

ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced that it will participate in the 2023 Truist Securities BioPharma Symposium, to be held from November 8-9, 2023 in New York, NY.

Dental implant manufacturer DIO USA finalized a deal to supply Patterson Dental with its DIOnavi system.

Govt to help local vaccine developers, ingredient makers with overseas expansion

To talk about raising taxes, cutting services, what kinds of things we need to do, what kind of sacrifices feed need to be made. we talked to old people, young people, experts, and people who just want to, you know, make sure that they can assure living standards for this country for their next generation and those beyond it. its 1:00 on saturday eastern time, 3:00 on sunday. hope you guys will stop by and watch. >> in place of "your $$$$$" this weekend, christine, you are never boring to me. ex...